ALI IBRAHIM: Open Payments
NPI 1710089388 · SAGINAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$232 in 11 payments from 7 companies in 2025. Trend: 2023 $178 · 2024 $802 · 2025 $232
Food & beverage: $232
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $90 |
| Janssen Pharmaceuticals, Inc | 2 | $47 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| ABBVIE INC. | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: ABILIFY ASIMTUFII, INVEGA SUSTENNA, Auvelity, COBENFY, VRAYLAR, CAPLYTA.
Industry payments across MI — which companies pay providers there.
